Kurzporträt
Mitarbeiterzahl: 160
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
John D. Hoekman
FOU | Founder | 43 | 01.01.08 |
Sheena Aurora
CTO | Chief Tech/Sci/R&D Officer | - | - |
Scott Youmans
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Sarah Wille
HRO | Human Resources Officer | - | 01.01.19 |
Lynn Gold
LAW | General Counsel | 67 | 01.07.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Timothy Nelson
BRD | Director/Board Member | 60 | 01.02.17 |
Diane Wilfong
BRD | Director/Board Member | 62 | 17.09.19 |
David Allison
BRD | Director/Board Member | 42 | 01.06.19 |
John D. Hoekman
FOU | Founder | 43 | 01.01.08 |
Darren Cline
BRD | Director/Board Member | 59 | 12.04.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 23 900 031 | 23 880 031 ( 99,92 %) | 0 | 99,92 % |
Unternehmenskontakt
Impel Pharmaceuticals, Inc.
201 Elliott Avenue West Suite 260
98119, Seattle
+206 568 1466
http://impelpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+38.65% | 39.36 Mrd. | |
-8.62% | 38.52 Mrd. | |
+26.95% | 30.74 Mrd. | |
+10.74% | 25.92 Mrd. | |
-13.50% | 26.03 Mrd. | |
+44.87% | 14.13 Mrd. | |
+34.36% | 12.73 Mrd. | |
-7.14% | 11.29 Mrd. | |
-12.61% | 10.64 Mrd. |